Holen Sie sich die Stockscreener-App
18.60
0.32%
0.06
Schlusskurs vom Vortag:
$18.54
Offen:
$18.62
24-Stunden-Volumen:
85,544
Relative Volume:
0.30
Marktkapitalisierung:
$477.81M
Einnahmen:
-
Nettoeinkommen (Verlust:
$11.77M
KGV:
32.15
EPS:
0.5785
Netto-Cashflow:
$-19.23M
1W Leistung:
+7.08%
1M Leistung:
+2.31%
6M Leistung:
+3.33%
1J Leistung:
+21.81%
1-Tages-Spanne:
$18.36
$18.93
1-Wochen-Bereich:
$17.07
$19.22
52-Wochen-Spanne:
$11.56
$29.79
Tourmaline Bio Inc Stock (TRML) Company Profile
Firmenname
Tourmaline Bio Inc
Sektor
Branche
Telefon
646-481-9832
Adresse
27 WEST 24TH STREET, NEW YORK
Vergleichen Sie TRML mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TRML
Tourmaline Bio Inc
|
18.60 | 446.21M | 0 | 11.77M | -19.23M | 0.5785 |
|
VRTX
Vertex Pharmaceuticals Inc
|
463.27 | 123.14B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
550.00 | 60.43B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
324.69 | 42.07B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
572.71 | 34.47B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
290.35 | 27.42B | 3.81B | -644.79M | -669.77M | -6.24 |
Tourmaline Bio Inc Stock (TRML) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-23 | Eingeleitet | Chardan Capital Markets | Buy |
| 2025-03-06 | Eingeleitet | Wedbush | Outperform |
| 2024-12-06 | Eingeleitet | BMO Capital Markets | Outperform |
| 2024-11-11 | Bestätigt | H.C. Wainwright | Buy |
| 2023-12-15 | Eingeleitet | Jefferies | Buy |
| 2023-12-04 | Fortgesetzt | H.C. Wainwright | Buy |
| 2023-11-17 | Eingeleitet | Truist | Buy |
| 2023-10-31 | Eingeleitet | Guggenheim | Buy |
| 2023-10-25 | Eingeleitet | Piper Sandler | Overweight |
| 2022-10-20 | Eingeleitet | H.C. Wainwright | Buy |
| 2022-07-05 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
Alle ansehen
Tourmaline Bio Inc Aktie (TRML) Neueste Nachrichten
What drives Tourmaline Bio Inc. stock priceAccelerated investment success - Jammu Links News
should you buy bull(mumu the bull erc)Free Top Growth Stock Recommendations - Newser
Why Tourmaline Bio Inc. stock attracts strong analyst attentionDouble Your Capital Alerts - Newser
How Tourmaline Bio Inc. stock performs during market volatilityFree Discussion Group - Newser
What makes Tourmaline Bio Inc. stock price move sharplyCarefully Curated High Return Stocks - Newser
What makes Universe Pharmaceuticals INC stock price move sharplyInsider Level Guidance - Newser
How Cross Country Healthcare Inc. stock performs during market volatilitySafe High Return Entry Points - Newser
How Orange County Bancorp Inc. stock performs during market volatilityDouble Profit With Half Risk - Newser
What makes Synopsys Inc. stock price move sharplyPro Trader Stock Focus - Newser
How KRON stock performs during market volatilityVerified Return Tips - Newser
Graves Ophthalmopathy Market Set to Grow Substantially Through 2034, DelveInsight Projects | Novartis, AdvanceCor, Apitope, Worg Pharma, AV7 Limited - Barchart.com
Avrupa Minerals (CVE:AVU) Trading 33.3% Higher – What’s Next? - Defense World
Tourmaline Bio, Inc. (NASDAQ:TRML) Shares Bought by California State Teachers Retirement System - Defense World
Cantor Fitzgerald Weighs in on Tourmaline Bio FY2026 Earnings - Defense World
Corrigendum: THE ROLE OF IL-6 IN THYROID EYE DISEASE: AN UPDATE ON EMERGING TREATMENTS - Frontiers
Correction: The role of IL-6 in thyroid eye disease: an update on emerging treatments - Frontiers
Two Sigma Investments LP Sells 21,904 Shares of Tourmaline Bio, Inc. (NASDAQ:TRML) - Defense World
Tourmaline Bio Releases Updated Corporate Presentation - TipRanks
Tourmaline Bio Elects Directors and Ratifies Auditor - TipRanks
Tourmaline Bio, Inc. (NASDAQ:TRML) Shares Bought by Bank of America Corp DE - Defense World
Nuveen Asset Management LLC Has $1.55 Million Stock Position in Tourmaline Bio, Inc. (NASDAQ:TRML) - Defense World
BNP Paribas Financial Markets Reduces Holdings in Tourmaline Bio, Inc. (NASDAQ:TRML) - Defense World
Jane Street Group LLC Cuts Stock Position in Tourmaline Bio, Inc. (NASDAQ:TRML) - Defense World
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Has $291,000 Stake in Tourmaline Bio, Inc. (NASDAQ:TRML) - Defense World
Deutsche Bank AG Grows Stock Holdings in Tourmaline Bio, Inc. (NASDAQ:TRML) - Defense World
Tourmaline Bio, Inc. (NASDAQ:TRML) Receives Average Recommendation of “Buy” from Brokerages - Defense World
BMO Sees Overreaction, Maintains Rating and Price Target on Tourmaline Bio (TRML) - MSN
H.C. Wainwright Maintains Buy Rating on Tourmaline Bio (TRML) After Promising Phase 2 Results - Insider Monkey
H.C. Wainwright maintains $50 target on Tourmaline Bio stock By Investing.com - Investing.com India
H.C. Wainwright maintains $50 target on Tourmaline Bio stock - Investing.com
Millennium Management LLC Has $7.40 Million Position in Tourmaline Bio, Inc. (NASDAQ:TRML) - Defense World
Leerink Partnrs Comments on Tourmaline Bio FY2026 Earnings - Defense World
Tourmaline Bio Shares Drop After Phase 2 Results for Obesity Drug Pacibekitug Fail to Meet Analyst Expectations - geneonline.com
Tourmaline Bio, Inc. (NASDAQ:TRML) Stock Position Lifted by Northern Trust Corp - Defense World
Leerink Partners Maintains Tourmaline Bio(TRML.US) With Buy Rating, Maintains Target Price $54 - 富途牛牛
BMO maintains $35 target on Tourmaline Bio, sees overreaction - Investing.com Australia
Tourmaline Bio stock holds $63 target post-Ph2 data By Investing.com - Investing.com Nigeria
BMO maintains $35 target on Tourmaline Bio, sees overreaction By Investing.com - Investing.com Nigeria
Tourmaline Bio stock holds $63 target post-Ph2 data - Investing.com
Finanzdaten der Tourmaline Bio Inc-Aktie (TRML)
Umsatz
Nettogewinn
Free Cashflow
ENV
Tourmaline Bio Inc-Aktie (TRML) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Kulkarni Sandeep Chidambar | CEO |
Aug 16 '24 |
Buy |
13.79 |
5,221 |
71,998 |
5,221 |
0.64%
0.37%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):